Quote Spy MDVN NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.



Enter Tickers





   Medivation (MDVN)
 
Click the portfolio to add MDVN:
Close [X]
+ Add MDVN to Portfolio
Last Trade: 29.22 +0.59 (2.06%) @ Nov-20

3-Month Chart (Larger chart w/volume)

Close [X]

1m  3m  6m  1y  2y 
Volume: 595,737 Avg Volume: 465,000
Day's Range: 28.60 - 29.25 52-wk Range: 11.27 - 29.00
Open: 28.61 Market Cap: 979.1M
Previous Close: 28.63 P/E: -24.7
Bid: 29.22 x 3 Div Yield: $0.00 (0.00%)
Ask: 29.89 x 5    
Spy MDVN
To see which Pros and tickerspy members own MDVN Sign up now
Indexes
Biotechnology Stocks (-0.4%)
Additional MDVN resources



Customize Links
Latest MDVN Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

To start a new thread post a Link or Note and tag it MDVN
Medivation upgraded to "buy"
MDVN  
Linked by newratings - November 06, 09:13AM from (www.newratings.com)
NEW YORK, November 5 (newratings.com) - Analysts at Roth Capital upgrade Medivation (ticker: MDVN) from "hold"  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Analyst upgrades, downgrades and initiations: CMCSA, GAME, GRMN, ETN, FO, MDT, MSO ...
TAP  ETN  MDT  D  FO  THQI  EDMC  VALE  NVAX  MDVN  MSO  ALVR  GRMN  CMCSA  YMI  AREX  GAME  
Linked by BloggingStocks - November 05, 11:30AM from (www.bloggingstocks.com)
Analyst upgrades:

Deutsche Bank upgraded Vale SA (NYSE: VALE) to Buy from Hold on expectations the company  more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update
MDVN  
Posted by PR Newswire - November 04, 04:01PM
SAN FRANCISCO, Nov. 4 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today reported on its corporate progress  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pfizer And Medivation Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer’s Disease
PFE  MDVN  
Linked by BusinessWire - November 03, 08:00AM from (www.businesswire.com)
Pfizer Inc (NYSE: PFE) and Medivation, Inc. (NASDAQ: MDVN) today announced the initiation of CONTACT and CONSTELLATION, two  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Medivation initiated with "overweight"
MDVN  
Linked by newratings - October 29, 02:13PM from (www.newratings.com)
NEW YORK, October 29 (newratings.com) - Analysts at JP Morgan initiate coverage of Medivation (ticker: MDVN) with an "overweight"  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Medivation (MDVN): Drug firm targets Alzheimer's
ICAD  MDVN  
Linked by BloggingStocks - September 14, 11:30AM from (www.pheedcontent.com)
For speculative investors aware of the risks associated with a development stage drug company, Karim Rahemtulla looks to  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pfizer And Medivation Initiate Phase 3 Trial Of Dimebon In Patients With Huntington Disease
PFE  MDVN  
Linked by BusinessWire - July 30, 08:30AM from (www.businesswire.com)
Pfizer Inc (NYSE: PFE) and Medivation, Inc. (NASDAQ: MDVN) today announced the initiation of a Phase 3 trial of the investigational  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Full 2009 ASCO Cancer & Oncology Primer
BMY  LLY  PFE  AMGN  PPHM  OSIP  CLDX  CELG  APPA  IMGN  MEDX  CTIC  EXEL  OGXI  MDVN  ARQL  ALTH  ZIOP  AEZS  ZGEN  GHDX  GSK  MITI  SNTA  TRBN  CGRB  ROSG  ABII  
Linked by 24/7 Wall St. - May 27, 02:34PM from (feedproxy.google.com)
We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3


 



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource